Cases of peripheral yellow corneal rings of AMD revealed

Article

Peripheral yellow corneal rings are more common in age-related macular degeneration (AMD).

Peripheral yellow corneal rings are more common in age-related macular degeneration (AMD) patients than previously thought, states a study in the journal Ophthalmology.

Dr Andrew W. Eller et al., Retina Service, UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA, conducted a retrospective single-centre case series on the medical records of four AMD patients with peripheral corneal rings receiving vitamin supplementation. The main outcome measures were the presence of peripheral yellow corneal rings, skin findings and serum carotene levels.

The results revealed that each patient had circumferential, yellow, peripheral corneal rings and demonstrated subtle yellowing of the skin- especially on the palms. In two patients serum carotene levels were normal, but in one patient the levels were significantly higher.

However, it is still uncertain how ophthalmologists should counsel patients with this condition. The rings may be misdiagnosed as arcus senilis or they may be too subtle to identify. Dr Eller suggests that a formal study on patients taking vitamin supplements of AMD should be completed.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.